baber/WOPTO huggingface dataset:
Patent CA-2581868-A1 (CA)
Title: Method and arrangement for the optical transmission of data signals by means of differential phase modulation in a polarization multiplex method
Inventor: SCHMIDT ERNST-DIETER
IPC: H04B10/67
Filed: 2005-09-20
Abstract: Two data signals are subjected to a binary differential phase modulation and transmitted as POLMUX multiplex signals. The types of modulation are selected in such a way that they are orthogonal in relation to each other and do not influence each other during the demodulation of the signals. There is thus no need to regulate the polarization on the receiving side.
Patent CA-2585214-A1 (CA)
Title: Cryoprotectant for use with a treatment device for improved cooling of subcutaneous lipid-rich cells
Inventor: EBBERS EDWARD A
IPC: A61F7/00
Filed: 2007-04-27
Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided . The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre- cooling of the treatment device below 0.degree.C while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.
Patent CA-2586121-A1 (CA)
Title: Maintaining uninterrupted service in a wireless access point and client stations thereof
Inventor: HUANG WENFENG
IPC: H04W36/38
Filed: 2005-12-29
Abstract: A method (Figure 1), an apparatus, and code in a carrier medium to operate in a first access point (101) of a wireless network in communication with at least one associated client station (105). The method includes wirelessly broadcasting a management frame including an indication that the first access point will stop being active, such that each associated client station can wirelessly roam to a second access point prior to the first access point ceasing being active. One embodiment further includes reducing the transmit power of wireless communication used to wirelessly transmit information to the associated client stations, such that each associated client station can eventually wirelessly roam to the second access point.
Patent CA-2587555-A1 (CA)
Inventor: KUEH LIP PIANG
IPC: C10G65/16
Filed: 2005-11-18
Abstract: Process to optimize the yield of gas oils from a Fischer-Tropsch derived feed by performing the following steps: (a) performing a hydroconversion/hydroisomerisation step on part of the Fischer-Tropsch derived feed; (b) performing a hydroconversion/hydroisomerisation step on another part of the Fischer-Tropsch feed at a conversion greater than the conversion in step (a); and (c) isolating by means of distillation a gas oil fraction from the two reaction products obtained in steps (a) and (b).
Patent CA-2587930-A1 (CA)
Inventor: BOURANG HENRY
IPC: A61B5/107
Filed: 2005-12-09
Abstract: A diagnostic device for determining the amount of change required in a coronary sinus to reduce valve regurgitation. The device includes a distal tube (14) having a distal anchor (18) at a distal end portion of the distal tube, a proximal tube (12) having a proximal anchor (16) at a distal end portion of the proximal tube, and an adjustor to move the distal tube relative to the proximal tube. The proximal tube and the distal tube together form a telescoping elongate body adapted to fit within the coronary sinus, and the device includes a scale (27) to measure the movement of the distal anchor relative to the proximal anchor.
Patent CA-2597003-A1 (CA)
Title: Analysis instrument
Inventor: MACNAMARA KENNETH G
IPC: B01L99/00
Filed: 2006-02-08
Abstract: The invention relates to an analysis instrument for processing a microiluidic device, comprising sample storage means, a microfluidic device holder, sample loading means for loading sample into a microfluidic device disposed in the holder, processing means for enabling a reaction in a microfluidic device, and detection means for detecting and/or measuring the reaction, characterised in that the microfluidic device holder is adapted to hold the microfluidic device comprising or including a tape in position for processing and/or detection.  The invention further relates to a microfluidic processing device, comprising a reaction chamber, a sample loading chamber into which a sample is injectable, the reaction chamber being operatively connected to the sample loading chamber, a cover that extends across at least part of the sample loading chamber, the cover and the reaction chamber comprising pierceable material and being separated by an overspill cavity configured to accept any overspill of an injected sample. Finally, the invention concerns a kit comprising an analysis instrument and a microfluidic processing device as described above.
Patent CA-2598674-A1 (CA)
Inventor: FERGUSON STEWART
IPC: B65D19/26
Filed: 2007-08-23
Abstract: A pallet is created from two sets of thin stringers crossing and mated orthogonally, forming forkway notches and including ribs to guide the fingers of lifting machinery through the pallet. The pallet may include an optional mortised deck.
Patent CA-2600614-A1 (CA)
Inventor: ROEHNER JUERGEN
IPC: C08L69/00
Filed: 2006-02-22
Abstract: The present invention relates to a solid sheet prepared from a composition that includes: (a) a transparent polycarbonate; and (b) transparent polymeric particles having an optical density which differs from the transparent polycarbonate matrix material. The present invention also relates to use of such a solid sheet as a diffuser sheet in flat screens.
Patent CA-2601380-A1 (CA)
Title: Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
Inventor: GAUDINO JOHN
IPC: C07D267/22
Filed: 2006-01-19
Abstract: Disclosed are compounds of the Formula (I) and diastereomers, tautomers, solvates, metabolites, and pharmaceutically acceptable salts thereof, wherein X, A, L and Y are as defined herein. Such compounds are useful in the treatment of immunoregulatory and respiratory diseases in mammals. Also disclosed are methods of using such compounds in the treatment of immunoregulatory and respiratory diseases in mammals and pharmaceutical compositions containing such compounds.
Patent CA-2602667-A1 (CA)
Title: Landing flap drive system
Inventor: RECKSIEK MARTIN
IPC: B64C13/38
Filed: 2006-04-12
Abstract: Nowadays, usually landing flap systems are used that comprise a central drive (101) with a central shaft transmission (102) to the drive stations. According to one embodiment of the present invention a landing flap drive system is stated, comprising a first drive motor (301, 302, 501) for operating a landing flap (107) . In this arrangement the landing flap drive system is essentially integrated in a track (509) of the landing flap (107) so that final assembly and integration of the system are facilitated to a significant extent.
Patent CA-2604706-A1 (CA)
Title: Determination of wheel sensor position using a single radio frequency detector in an automotive remote tire monitor system
Inventor: STEWART WILLIAM DAVID
IPC: B60C23/00
Filed: 2006-04-13
Abstract: A tire monitor system employs a single RF detector mounted on the vehicle. The tire monitor system also includes a control unit and a receiver. The single RF  detector is positioned to be proximate a front axle or a rear axle. The RJF  detector also may be positioned off-center. The control unit distinguishes front tire monitors from rear tire monitors by comparing a number of RJF  transmissions received by each tire monitor. The control unit also may distinguish between left tire monitors and right tire monitors by comparing the number of RF transmissions received by each tire monitor. In other embodiment, the tire monitor system may further use a received signal strength and/or acceleration signals to determine position information of the tire monitors.
Patent CA-2606338-A1 (CA)
Title: Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
Inventor: DAVIDSON ALAN HORNSBY
IPC: A61K31/495
Filed: 2006-05-04
Abstract: Compounds of formula (IA) or (IB), are inhibitors of aurora kinase activity: Formula (IA), (IB) wherein -L1Y1-[CH2]z- is a linker radical wherein Y1, L1 and z are as defined in the claims; R6 is C1-C4alkoxy, hydrogen or halo; W represents a bond, —CH2—, —O—, —S—, —S(═O)2—, or —NR5— where R5 is hydrogen or C1-C4 alkyl; Q is ═N—, ═CH— or ═C(X1)— wherein X1 is cyano, cyclopropyl or halo; linker radicals L2 are as defined in the claims; R is a radical of formula (X) or (Y): wherein R1 is a carboxylic acid group (—COOH), or an ester group which is hydrolysable by one or more intracellular carboxylesterase enzymes to a carboxylic acid group; R4 is hydrogen; or optionally substituted C1-C6 alkyl, C3-C7 cycloalkyl, aryl, aryl(C1-C6 alkyl)-, heteroaryl, heteroaryl(C1-C6 alkyl)-, —(C═O)R3, —(C═O)OR3, or —(C═O)NR3 wherein R3 is hydrogen or optionally substituted (C1-C6)alkyl, C3-C7 cycloalkyl, aryl, aryl(C1-C6 alkyl)-, heteroaryl, or heteroaryl(C1-C6 alkyl)-; R41 is hydrogen or optionally substituted C1-C6 alkyl; and D is a mono-cyclic heterocyclic ring of 5 or 6 ring atoms.
Patent CA-2606837-A1 (CA)
Title: Space refueling stations
Inventor: VOON GERARD
IPC: B64G1/42
Filed: 2007-10-19
Abstract: Our invention is to build unfurling solar refuelling stations at points along the way between Earth, the Moon and Mars.   The fuel stations pace/floating (from its real time satellite position) with adjustments (possibly with help Artificial Intelligence and ground control) in direction, speed, momentum needed with retro rockets (to adjust for over and/or under timing) to meet the future (expected;  targeted) flight path of the space shuttle route.   We could also triangulate via, the Earth - Moon (Signals) or other stationary/floating signaller and the relative place of the nearest refuelling station versus the relative place of the space shuttle.
Patent CA-2609311-A1 (CA)
Title: Procede de preparation de composes organosiliciques en milieu biphasique
Inventor: STERIN SEBASTIEN
IPC: C07F7/18
Filed: 2006-05-17
Abstract: Le domaine de l'invention est celui de la synthèse de composés organosiliciques fonctionnalisés comprenant au moins un groupe azo activé, de formule (I) : [(G0)3SiO1/2]m [(G0)2SiO2/2]n [G0SiO3/2]o [SiO4/2]p [(G2)a(G1)a'(Z-CO-HN=NH-CO-A)SiO(3-a-a')/2]. Ce procédé consiste à mettre en AEuvre au moins un précurseur (II) hydrazino (-HN-NH-) du composé (I), à  oxyder le précurseur (II) en groupement azo propre au composé (I), à l'aide d'un système oxydant comprenant au moins un oxydant (Ox) et au moins une base (B), ce procédé étant caractérisé en ce que l'oxydation est réalisée en milieu biphasique aqueux/organique et en ce que l'on fait en sorte que le pH de la phase aqueuse soit compris entre 3 et 11, de préférence entre 5 et 9.  L'invention concerne également les composés (I) stables à la chaleur susceptibles d'être obtenus par ce procédé.
Patent CA-2617435-A1 (CA)
Title: Starter car for a drilling device
Inventor: EBNER BERNHARD
IPC: E21B7/04
Filed: 2006-07-26
Abstract: A base for a drilling device for underground excavations has a base frame (5) mounted so as to rotate about a vertical axis (6) and a base pipe (7) rotatable about a substantially horizontal axis (13) for receiving the drilling device. The base pipe (7) is arranged so as to slide in relation to the base frame (5) transversely to the horizontal rotational axis (13).
Patent CA-2617737-A1 (CA)
Title: Dimensional control of concrete blocks
Inventor: TUFTS PAUL RANDAL
IPC: B28B7/24
Filed: 2006-07-25
Abstract: A concrete block mold division plate (26) for front-face-up block molding. The division plate fits into a channel (44) formed in each of the side walls (22) of the mold(20) . A plurality of fasteners (48) secure the division plate (26) within each channel and to the side walls of the mold. The division plate operates in conjunction with an optimized dry cast concrete mixture to provide acceptable control of the flatness and parallelism of the top (86) and bottom(88) surfaces of the blocks(80) .
Patent CA-2618387-A1 (CA)
Inventor: HAKE CHARLES L
IPC: B04B1/00
Filed: 2006-08-14
Abstract: A bag loading means (87) is for loading and unloading at least one satellite bag (2, 3, 4) into and from the central compartment (34) of a rotor (32, 33, 34, 35) of an apparatus for separating a composite liquid into at least two components. The bag loading means (87) comprises an upper part comprising securing means (92) for removably securing an upper portion of at least one satellite bag (2, 3, 4) to the bag loading means (87); a lower part comprising a receptacle (96) for containing a lower portion of at least one satellite bag (2, 3, 4); and an intermediate part connecting the upper part to the lower part and exposing an intermediate portion of a satellite bag (2, 3, 4) having an upper portion secured to the upper part of the loading means (87) and a lower portion inserted in the receptacle.
Patent CA-2622707-A1 (CA)
Title: Satellite printing unit of a web-fed printing press
Inventor: REHM MARC
IPC: B41F7/10
Filed: 2008-02-22
Abstract: A satellite printing unit of a web-fed printing press with printing couples is disclosed. Each printing couple includes a plate cylinder and a transfer cylinder where the transfer cylinders of all the printing couples roll off a common impression cylinder. Each plate cylinder features a high lockup slot and a low lockup slot and each transfer cylinder has a lockup slot. The transfer cylinders of the printing couples are aligned relative to the plate cylinders of the printing couples such that, on a first group of printing couples, which includes at least one printing couple, the lockup slot of the respective transfer cylinder rolls over the high lockup slot of the respective plate cylinder and on a second group of printing couples, which includes at least one printing couple, the lockup slot of the respective transfer cylinder rolls over the low lockup slot of the respective plate cylinder.
Patent CA-2624030-A1 (CA)
Title: Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
Inventor: LIU JIAN
IPC: A61P15/00
Filed: 2006-09-25
Abstract: Certain novel N-acylated spiropiperidine derivatives are ligands of the human melanocortin receptor(s) and, in particular, are selective ligands of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of MC-4R, such as obesity, diabetes, nicotine addiction, alcoholism, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Patent CA-2624323-A1 (CA)
Title: Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders
Inventor: PERZBORN ELISABETH
IPC: A61P9/00
Filed: 2006-09-22
Abstract: The invention relates to combinations of A) oxazolidinones of formula (I) and B) antiarrhythmics, methods for producing said combinations, the use thereof for treating and/or preventing diseases, and the use thereof for producing medicaments utilized for the prevention and/or treatment of diseases, particularly thromboembolic diseases and/or complications.
Patent CA-2624786-A1 (CA)
Title: Aerosol formulation for the inhalation of beta-agonists
Inventor: NIKLAUS-HUMKE BARBARA
IPC: A61K9/00
Filed: 2006-10-06
Abstract: The invention relates to an aerosol formulation for inhalation that is devoid of a propellant and contains one or more compounds of general formula (1) and an additional active ingredient (2). In said formula, the groups R1, R2, R3 and X- can be defined as cited in the claims and the description.
Patent CA-2626201-A1 (CA)
Inventor: GALL PIERRE-EMMANUEL
IPC: B64D27/14
Filed: 2006-10-23
Abstract: The aircraft has one or more turboprop engines (7) with lengthwise axes (L-L) parallel to the lengthwise axis (X-X) of the aircraft, mounted on pylons (8) on a rear cell of the aircraft fuselage that acts as a noise barrier. Depending on the number of engines and the tail assembly configuration, the turboprop engines are located between vertical fins (5) and/or horizontal tailplanes (6), with contrarotating twin propellers (9, 10) located to the rear of the engines and as far as possible towards the rear of the aircraft. The aircraft can be propelled by turboprop engine(s) alone or a combination of turboprop and under-wing turbojet engines.
Patent CA-2627700-A1 (CA)
Title: Systems and methods for detecting and presenting textural information from medical images
Inventor: SATHYANARAYANA SHASHIDHAR
IPC: G01S7/52
Filed: 2006-10-31
Abstract: The invention is directed to systems and methods for detecting and presenting textural information from medical images. In one embodiment, a medical imaging system includes an imaging transducer assembly configured to emit one or more energy pulses and receive one or more echo signals, and a console, coupled to the imaging transducer assembly, configured to receive the one or more echo signals, generate an uncompressed image based on the one or more echo signals, generate a log compressed image based on the uncompressed image, generate a color overlay based on the uncompressed image, and apply the color overlay to the log compressed image.
Patent CA-2631466-A1 (CA)
Title: Milieu de culture de cellules microfluidique
Inventor: HEO YUN SEOK
IPC: C12M3/00
Filed: 2006-12-04
Abstract: La présente invention concerne un milieu de culture cellulaire microfluidique qui peut avoir une concentration initiale en un matériau actif inférieure à une fenêtre thérapeutique de concentration nécessaire pour fournir à une masse cellulaire un environnement thérapeutique.
Patent CA-2631595-A1 (CA)
Inventor: WINTER ELSBETH
IPC: A61L27/14
Filed: 2006-12-01
Abstract: Use is claimed in ophthalmological devices of a polymer composition obtained by polymerization of (A) a main monomer which is a substituted (meth)acrylic ester or a substituted acrylamide of specified formula; (B) a crosslinking monomer; and optionally (C) a comonomer to adjust properties such as refractive index, surface properties, glass transition temperature, strength properties, UV absorption and/or color. Use is claimed in ophthalmological devices of a polymer obtained by polymerization of (A) a main monomer which is a substituted (meth)acrylic ester or a substituted acrylamide of formula (I); (B) a crosslinking monomer; and optionally (C) a comonomer to adjust properties such as refractive index, surface properties, glass transition temperature, strength properties, UV absorption and/or color. X : O or NR c>; Y : O, S or NR c>; R : 1-6C optionally cyclic hydrocarbon group; R a>H or methyl; R b>H, 1-5C alkyl or Y-Ar 3>; R c>H, 1-6C optionally cyclic hydrocarbon group or aryl; and Ar 1> - Ar 3>aryl bonded to Y by a bridge or via -(CH 2) 0-3-, the aryl optionally having 1-4C substituents comprising 1-5C alkyl or alkoxy or mono- or di-R c>-substituted amino. An independent claim is also included for preparation of the polymer composition. [Image] [Image].
Patent CA-2631890-A1 (CA)
Inventor: SONE TAKUO
IPC: C08K3/36
Filed: 2006-12-05
Abstract: A process for simply and inexpensively producing a conjugated diene polymer with a narrow molecular weight distribution and a high cis-bond content at a low cost is provided. The process comprises a polymerization step, wherein a conjugated diene polymer having a cis-1,4-bond content of 98 5 mass% or more and a ratio (Mw/Mn) of the weight average molecular weight (Mw) to the number average molecular weight (Mn) measured by gel permeation chromatography of 2.5 or less is obtained by carrying out a polymerization reaction in conjugated diene compounds using a catalyst composition containing a rare earth element-containing compound or a reaction product of the rare earth element-containing compound with a Lewis base, an aluminoxane and/or organoaluminum compound, and an iodine-containing compound
Patent CA-2632841-A1 (CA)
Title: Interventional deployment and imaging system
Inventor: GROSSMAN JESSICA
IPC: A61B8/14
Filed: 2007-01-10
Abstract: Needle deployment and imaging system includes a sheath, an imaging core, and interventional core. The imaging core and interventional core are received in first and second axial passages in the sheath and at least one of said cores will be removable and replaceable within the sheath. The imaging core may be extended from the sheath or be sealed within the first axial passage of the sheath. The interventional core will typically be advanced laterally or axially from a location near the distal end of the sheath.
Patent CA-2633196-A1 (CA)
Title: Recording apparatus with remaining capacity detection unit
Inventor: HASHIMOTO SATOSHI
IPC: H04H20/00
Filed: 2006-12-18
Abstract: The broadcast recording and reproduction apparatus (1300) which limits loss of content to a minimum includes: a recording generation unit (2801) which records data included in a broadcast signal into a unit-region; a volume remainder detection unit (2813) which detects the remaining capacity, within the unit-region, that can be recorded into; a volume remainder insufficiency sensing unit (2802) which senses that the remaining capacity goes below a predetermined capacity; a remainder insufficiency handler which is called when it is sensed that the remaining capacity goes below the predetermined capacity; and a remainder insufficiency handler registration unit (3301) which registers the remainder insufficiency handler. The remainder insufficiency handler registered in the remainder insufficiency handler registration unit (3301) is called.
Patent CA-2634119-A1 (CA)
Title: A porous membrane device that promotes the differentiation of monocytes into dendritic cells
Inventor: HIGBEE RUSSELL
IPC: G01N33/00
Filed: 2006-12-21
Abstract: Dendritic cells (DCs) for research and clinical applications are typically derived from purified blood monocytes that are cultured in a cocktail of cytokines for a week or more. Because it has been suggested that these cytokine-derived DCs may be deficient in some important immunological functions and might not accurately represent antigen-presenting cell (APC) populations found under physiologic conditions, there is a need for methods that allow the generation of DCs in a more physiologically relevant manner. The present invention comprises a simple and reliable technique for generating large numbers of highly purified DCs, based on a single migration of blood monocytes through endothelial cells that are cultured in, for example, a Transwell® device. The resultant APCs, harvested from the lower Transwell® chamber, resemble other  in vitro -generated DC populations in their expression of major histocompatability (MHC) and costimulatory molecules, ability to phagocytose foreign antigens, and capacity to trigger antigen-specific T cell responses.
Patent CA-2635061-A1 (CA)
Title: A deflectable stylet
Inventor: OGLE DAVID
IPC: A61M25/092
Filed: 2008-06-13
Abstract: A deflectable stylet 10 for a catheter includes an elongate- deflectable member 12 with a bend-enhancing region 20 defined at a distal part of the deflectable member 12. An actuator16 has a distal end 16. 1 fast with a distal end 12.1 of the deflectable member 12, relative displacement between the actuator 16 and the deflectable member 12 causing deflection of the distal part of the deflectable member 12 at the bend-enhancing region 20. A control member 18 is displaceably arranged relative to the deflectable member 12, the control member 18 interacting with the bend-enhancing region 20 of the deflectable member 12 for controlling the extent of deflection of the distal part of the deflectable member 12.